CIK 0001232524
- Large accelerated filer
Jazz Pharmaceuticals plc
Sign in to watch- Ticker
- JAZZ
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Ireland
- Entity type
- Operating
- EIN
- 981032470
- Phone
- +353 16347800
- Business address
- FIFTH FLOOR, WATERLOO EXCHANGE, WATERLOO ROAD, DUBLIN, Ireland, D04 E5W7
- Former names
- JAZZ PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $41,420,682
- in 10 filings, $24.9M under 10b5-1 plans
Net −$41,420,682. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- COZADD BRUCE C −$20.4M Director sold 20% of stake
- Iannone Robert −$19.2M EVP, Global Head of R&D & CMO sold 54% of stake
- GALA RENEE D −$1.2M President & CEO sold 3% of stake
- Carr Patricia −$327K SVP, Chief Accounting Officer sold 18% of stake
- Patil Neena M −$289K EVP & Chief Legal Officer sold 2% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-02-25 | GALA RENEE D EVP & CFO | Grant or award | +10,115 | 26,862 | ||
| 2021-02-25 | COZADD BRUCE C Chairman & CEO | Grant or award | +37,925 | 355,957 | ||
| 2021-02-25 | Carr Patricia VP, Finance & PAO | Grant or award | +1,895 | 8,095 | ||
| 2021-02-25 | Smith Mark Douglas Director | Grant or award | +2,590 | 2,590 | ||
| 2021-02-25 | Smith Mark Douglas Director | Grant or award · Non-Qualified Stock Option (right to buy) | +6,475 | 6,475 | ||
| 2021-02-25 | Cook Jennifer E. Director | Grant or award | +2,590 | 2,590 | ||
| 2021-02-25 | Cook Jennifer E. Director | Grant or award · Non-Qualified Stock Option (right to buy) | +6,475 | 6,475 | ||
| 2021-02-03 | COZADD BRUCE C Chairman & CEO | Sale | −250 | $160.00 | $40K | 318,032 |
| 2021-02-01 | COZADD BRUCE C Chairman & CEO | Sale | −1,250 | $156.15 | $195K | 318,282 |
| 2021-01-04 | COZADD BRUCE C Chairman & CEO | Sale | −7,950 | $162.01 | $1.3M | 319,532 |
| 2021-01-04 | Swisher Daniel N JR President and COO | Shares withheld for taxes | −1,607 | $160.40 | $258K | 41,984 |
| 2020-12-04 | Carr Patricia VP, Finance & PAO | Sale | −62 | $152.55 | $9K | 6,200 |
| 2020-12-03 | COZADD BRUCE C Chairman & CEO | Sale | −250 | $150.00 | $38K | 327,482 |
| 2020-12-01 | COZADD BRUCE C Chairman & CEO | Sale | −1,000 | $140.58 | $141K | 327,732 |
| 2020-11-12 | ENRIGHT PATRICK G Director | Sale | −3,223 | $145.81 | $470K | 27,074 |
| 2020-11-12 | ENRIGHT PATRICK G Director | Sale | −5,083 | $147.00 | $747K | 21,991 |
| 2020-11-12 | ENRIGHT PATRICK G Director | Sale | −1,623 | $147.61 | $240K | 20,368 |
| 2020-11-06 | Larkin Finbar SVP, Technical Operations | Sale | −197 | $151.93 | $30K | 13,964 |
| 2020-11-05 | O'Keefe Kenneth W Director | Sale | −2,001 | $152.57 | $305K | 27,666 |
| 2020-11-05 | O'Keefe Kenneth W Director | Sale | −2,740 | $153.74 | $421K | 24,926 |
Page 34 of 39 · 780 trades